What is Propylthiouracil?

Propylthiouracil or PTU is an antihyroid drug used in the treatment of excessive thyroid gland to reduce the levels of the thyroid hormone in the body. This drug can be used separately as a solo form of therapy to reduce the patient's hormones and keep them safe. It can also be used in patients who are preparing for surgical treatment of hyperthyroidism. One of the most common reasons to prescribe this drug is the treatment of grave disease, common causes of hyperthyroidism.

This drug was approved for use in the 40th century. It comes in the form of tablets. Initial doses are usually high to force thyroid hormone levels to decline, and over time the patient is narrowed to a lower dosage for long -term use. The patient will be monitored by an endocrinologist because the dose is treated to find that thyroid hormone production remains stable and balanced. Subsequent meetings can be used to confirm that the treatment still works a good patient.

Propylthiouracil FUNG is blocking the production of thyroid hormone in the body. It inhibits the action of enzymes involved in hormone synthesis. Medicines begin to work in the body very quickly and the life of the dose can be eight hours or more. The most common side effects associated with the use of propylthiouracil are related to the skin. Patients may develop rashes, itching, hives and other forms of skin irritation as a reaction to drugs.

Less commonly can cause drugs such as nausea, joint pain, swelling, vomiting and headache. Patients may also develop bleeding disorders and decreased white blood cells. Studies show that Propylthiouracil is dangerous during pregnancy, although there may be cases where concerns about the health of the mother outweigh this risk and propylthiouracil is safer than some other anti -rigid drugs, which I do the best choice when hyperthyroidism of a pregnant woman must be absolutely controlled pharmacologically.

inIn 2009, the administration of food and drugs in the United States recorded an increased incidence of severe jar problems in patients taking Propylthiouracil and in 2010 added a warning to a prescription package. People with a history of liver disease may not be able to take this medicine and periodic testing of liver function in patients can be recommended to monitor the liver condition, allowing doctors to take quick steps if the patient begins to experience an undesirable reaction to the drug.